Cases filed by hundreds of women against the pharmaceutical company Bayer alleging harm by its medical device Essure are being coordinated for pretrial proceedings in California.
Since the Affordable Care Act eliminated certain out-of-pocket costs, the mammography rate has increased, according to a study published Monday.
Robert F. Kennedy Jr, a vocal vaccination skeptic, says President-elect Donald Trump has asked him to chair a commission on vaccine safety.
Approvals for new drugs dropped to a six-year low in 2016. Industry insiders are optimistic that the recently passed 21st Century Cures Act will speed up the process.
Starting with President George W. Bush, the U.S. stepped up its commitment to improving health outcomes in less developed countries. But funding hit a plateau in 2010.
The next time you take a shower, you might want to look above. To the showerhead, precisely … and wonder what's lurking inside.
In other cases filed against Bayer over injuries related to Essure, the company has claimed it is not liable because a federal agency approved the device. This idea, known as federal preemption, could effectively grant Bayer immunity, but lawyers are optimistic that it won't.
Fewer hospital-acquired conditions avoided some 125,000 patient deaths and saved $28 billion, the administration said in a report released Monday. In some places, however, the report contradicted findings released a week before by the CDC.
A new collaboration between four healthcare organizations may help users ask better questions about safety, efficacy, privacy and interoperability when they consider purchasing mobile apps.
Patients who received help accessing food and medication subsequently improved their cholesterol levels and blood pressure. A recent study is the first to link intervention and outcome, although the findings do not prove that addressing social needs improves clinical indicators.
Those still stumped on what to buy for their loved ones this holiday season, might consider, adopting and gifting a HeroRAT.
Little known to the public, a group of public and private stakeholders convene annually to scrutinize measures that influence how large sums of taxpayer-funded healthcare dollars are spent.